Revised. Amendments from Version 1
==================================

The purpose of the study was better explained at the end of the Introduction. It was the objective to identify all the various processes/sub-processes involved in data sharing and to provide a listing and classification of tools/services that could usefully support those processes. The methodological section of the manuscript was revised and adapted as much as possible to the COREQ guidelines for qualitative research. The credentials and experience of the authors was described, the rationale for data collection specified, the limitations of the initial CORBEL exercise characterised and the methodological approach specified in detail. The tables were improved according to the suggestions of the reviewers. The almost entirely unused column for "Subservices" was removed and the few entries transferred to the column "Possible Services / Tools".  That made the table simpler and easier to read. Figure 1 was extended with an optional relation between "Data requester" and "Data generator" and a reference that preparation of data sharing may also take place after data update has been added. In addition, minor corrections have been performed in the text to improve clearness and readability.
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Introduction
============

In recent years, many scientific organisations, funders and initiatives have expressed their commitment to more open scientific research. This cultural shift has been extended to also include clinical research and clinical trials in particular. Today, the results of clinical trials are increasingly considered as a public good, and access to the individual participant data (IPD) generated by those trials is seen as part of a fundamental right to health data (see [Research Councils UK principles on data policy](http://www.rcuk.ac.uk/research/datapolicy/)). At the same time, any release of data must include mechanisms to maintain the privacy of the trial participants, and properly recognise the work of the researchers who initially generated the data.

To support the sharing of IPD in clinical trials, several organisations have developed generic principles, guidance and practical recommendations for implementation in recent years (e.g. the Institute of Medicine report in the US ^[@ref-1]^, the Nordic Trial Alliance Working Group on Transparency and Registration for the Nordic countries ^[@ref-2]^, the good practice principles for sharing IPD from publicly funded trials by MRC, UKCRC, CRUK and Wellcome, in the UK ^[@ref-3],\ [@ref-4]^, the guide to publishing and sharing sensitive data for Australia ^[@ref-5]^ and the recommendations of the International Committee of Medical Journal Editors (ICMJE, see [ICMJE recommendations on clinical trials](http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html)). Within the EU Horizon 2020 funded project CORBEL (Coordinated Research Infrastructures Building Enduring Life-science Services) and coordinated by the European Clinical Research Infrastructure Network (ECRIN), an interdisciplinary and international stakeholder taskforce reached a detailed consensus on principles and recommendations for data sharing of clinical trial data ^[@ref-6]^. That document was taken as the starting point for the current paper.

Data sharing of IPD from clinical trials can be complex and will often involve the interaction of many actors. At present only limited documentary support is available, (e.g. templates for data sharing plans, data transfer and data use agreements), and this is scattered and thus not always easy to find. In addition, although some IT-tools and services are available to give support for individual tasks in the process of data sharing (e.g. for de-identification service for datasets; see [Electronic Health Information Laboratory page on de-identification software](http://www.ehealthinformation.ca/faq/de-identification-software-tools/)) or an ID-generation service for study objects), these are again difficult to discover and their quality is not easy to assess. Additional complexity stems from the very heterogeneous set of repositories that are available for storage of IPD (see [Registry of Research Data Repositories](https://www.re3data.org/)). There are general scientific repositories, repositories dedicated specifically to clinical research, repositories specialising a specific disease area and institution-specific repositories. Thus, although fragments of infrastructure are available to support sharing of IPD from clinical trials, the various services and tools are scattered and a global vision of how all these components should interact and interoperate does not currently exist.

Fundamentally, what is still missing is a generic framework or architecture for data sharing that could be used for modelling, describing, and designing operations, data requirements, IT-systems and technological solutions (see [Open Group TOGAF® framework](http://www.opengroup.org/subjectareas/enterprise/togaf)). Such a framework would link structural concepts (e.g. actors) with behavioural concepts (e.g. processes supported by services) and give an overview of how these could interact to form a complete system for data sharing of IPD. As a first step in creating such a general framework, we set out to identify various processes and subprocesses that could be involved and then provide a listing and classification of the tools and services that could usefully support those processes. It was not intended at this stage, to provide tools themselves (e.g. guidelines, examples, templates, IT-systems). This work is seen, however, as a necessary preparatory step for identifying and/or generating tools in a later stage of the CORBEL project.

Methods
=======

In this study, a semi-formal collaborative small group decision-making approach was used to derive and then critique the list of processes and subprocesses involved in data sharing. The work is non-quantitative and we have therefore applied elements of the [COREQ guidelines](http://www.equator-network.org/reporting-guidelines/coreq/) for qualitative research, as applicable in the following discussion of methods.

Credentials and experience of authors
-------------------------------------

CO, RB, SC and SB were members of the core team that coordinated the H2020 CORBEL working task on sharing of individual participant data from clinical trials lead by ECRIN. The team coordinated a consensus exercise of the multi-stakeholder taskforce and drafted the final report on "Sharing and reuse of individual participant data from clinical trials: principles and recommendations" ^[@ref-6]^. WK was one of the experts within the multi-stakeholder taskforce.

The authors have different background and expertise, but all have a longstanding practical experience with clinical trials. CO has a PhD in mathematics and was head of an academic clinical trial unit with a focus on biostatistics and IT-support of trials; SC has an MSc in information systems and he is an expert in data management and IT systems for clinical trials, RB is a clinical pharmacologist with an expertise in clinical trial and evidence synthesis methodology; WK has a PhD in molecular genetics with education in clinical pharmacology and he is an expert of information science; SB has a PhD in biological sciences and is the project manager responsible for the CORBEL project for ECRIN.

Using a multi-stakeholder group of 40+ international experts, and a formal consensus building process, an overarching framework for IPD sharing and reuse was developed in the CORBEL project. That process was co-ordinated by and involved the extensive participation of the core team. The document produced covers all stages of the data sharing life cycle and is highly structured, with 7 main topics, 10 principles assigned to these topics and 50 specific recommendations, making the analysis of the processes and subprocesses involved in IPD sharing relatively straightforward. This process analysis can be considered a first step in translating these CORBEL's principles and recommendations into actionable strategies, leading to implementation guidelines and the supporting services required for successful data sharing projects.

Rationale for data collection
-----------------------------

Other work on the sharing of IPD from clinical trials has usually been embedded in a geographical/national context (eg, US, Nordic countries, UK), or centred on a specific stakeholder group (eg. Pharma) or focused on a specific subset of clinical trial data (e.g. published data). Due to the heterogeneity of the different documents, it was decided not to attempt a systematic review. Instead these and other documents were taken into consideration in the initial CORBEL consensus exercise and, as a consequence, in the final report ^[@ref-6]^. Within this report we provided up to date, precise, broadly based and workable recommendations supporting data sharing from clinical trials. The report was generic though focus of the report was on non-commercial trials, a European origin and the perspective of the researcher. The CORBEL report provided the basis for this study ^[@ref-6]^.

Limitations of the initial CORBEL consensus exercise
----------------------------------------------------

A limitation of the initial study was that the consensus building exercise was largely based on experience and opinions, and members of the task force may not have been fully representative of the research community. The other major issue is that the recommendations need to be implemented and tested in practice, and their feasibility and usability explored.

Methodological approach
-----------------------

The basic concepts and definitions were adapted from the business process model and notation (BPMN) and applied to our analysis. Recommendations and principles from the data sharing consensus document were analysed in detail and individual processes and subprocesses identified and linked to actors and possible services and tools by a small group of experts (CO, SC, RB, WK, SB). The decision-making process was based on a facilitator (CO) providing initial and updated versions of the document and iterative rounds of written feedback from the team members. The process was continued until final agreement was achieved. The process took place between October 2017 and January 2018, four different versions were provided and approved in sequential order (24 November 2017, 7 and 11 December 2017, 15 January 2018). Due to the good relationship between the team members and long-term involvement in common projects, a comprehensive and detailed point of reference, the consensus document, and clear objectives with milestones and time lines, agreement could be achieved by the team without applying a normative model of decision-making. The protocol for the qualitative analysis of the processes was not registered.

***Definitions*.** The following definitions were adapted from the business process model and notation (BPMN) and applied to our analysis (see [Object Management Group page](http://www.bpmn.org/), [@ref-7]):

***Process:***                  A sequence or flow of activities in an organization with the objective of carrying out work (see [Object Management Group page](http://www.bpmn.org/)).

***Subprocess:***              A process that is included within another process (see [Object Management Group page](http://www.bpmn.org/))

***Actor:***                  Some person or organization taking part in day-to-day business activity (see [Object Management Group page](http://www.bpmn.org/))

***Service:***                  A service is a functional business entity that fulfils a particular requirement (see [Open Science and Research framework](https://openscience.fi/framework-for-open-science))

In this study, processes may relate to different organisations and business goals, e.g. the various activities of the data generators, data storage managers and secondary users all represent *different* business processes, operating at different times by different actors.

Actors are belonging to or have a relationship with the clinical trial arena. Actors include: investigators, trial unit heads, QA-staff, senior data management and IT-staff, trial unit operational managers, statisticians, sponsors, trial management team, specialist agencies, repository managers, analysis environment providers, secondary users of data, data use advisory panel, research infrastructures, journal publishers, patient representatives, and funders. Definitions of actors have been taken from the glossary in the consensus document ^[@ref-6]^ and some from the [CDISC-glossary](https://www.cdisc.org/standards/semantics/glossary).

Services and tools may be relatively non-technical (e.g. providing information, example materials, template policies and procedures, assessment criteria, metadata, and infrastructure specifications) or technical, i.e. information technology based. For the most part, the IT required is seen as relatively well established (e.g. webpages, web-based information systems) and already available (though would normally need specific organisation and application). A few services and tools may require specialist software development (e.g. development of an analysis environment, developing systems to support metadata repositories).

For graphical illustration, the BPMN approach was used. In BPMN, a process is depicted as a graph of flow elements, which are a set of activities, events, gateways, and sequence flow that adhere to a finite set of execution semantics. The usual BMBP notation and symbols were taken (event, activity, gateway, connections, swim lane) (see [Object Management Group page](http://www.bpmn.org/)). In this publication, BPMN is used only to give a high-level overview of the relation between the main processes. We may use the same notation in the future to 'drill down' into individual processes to provide a more detailed graphical representation.

Results
=======

From the analysis of the consensus document 9 **groups of processes** involved in sharing of IPD were identified. These were concerned with:

1\. Preparation for data sharing, in general (3)

2\. Plan for data sharing, in the context of a specific trial (5)

3\. Preparation of data for sharing, after data collected (3)

4\. Transferring data objects to an external repository (2)

5\. Repository data and access management (6)

6\. Access to individual participant data and associated data objects (2)

7\. Discovering the data objects available (5)

8\. Publishing results of re-use (1)

9\. Monitoring data sharing (2)

The numbers in brackets refer to the number of distinct processes identified within each group. Group 1 to 5 can be summarized under the heading "Data preparation and storage", and 6--9 under the heading "Data request and secondary analysis". The relationship between these major process groups is presented in [Figure 1](#f1){ref-type="fig"}.

![Overview on the main processes in sharing of IPD.](f1000research-7-15913-g0000){#f1}

Almost all of the 29 processes were broken down further to 2 or 3 subprocesses, occasionally more and each subprocess was linked to the main actors involved and possible services and / or tools. As result a detailed and comprehensive list of the individual activity involved in data sharing is provided by [Table 1](#T1){ref-type="table"}.

###### Listing of processes, actors and possible services/tools in sharing of IPD from clinical trials.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Process                                                                        Subprocess                                              Main Actors                                                                    Possible Services/Tools
  ------------------------------------------------------------------------------ ------------------------------------------------------- ------------------------------------------------------------------------------ -----------------------------------------------
  1\. Preparation for data sharing, *in general*                                                                                                                                                                        

  1.1 Learn about individual\                                                    1.1.1 Learn about policies, requirements,\              Investigators, trials unit ^[2](#FN2){ref-type="other"}^ heads, operational\   Education service (web pages, videos,\
  participant data (IPD) and data\                                               implications, options, resources, etc.                  managers, patient groups                                                       courses, texts etc.)
  object sharing ^[1](#FN1){ref-type="other"}^.                                                                                                                                                                         

  1.1.2 Become aware of repositories available for\                              Investigators, trials unit heads, operational\          Web based information sources on\                                              
  data sharing, features, pros and cons, costs, etc.                             managers                                                repositories, published surveys, repository\                                   
                                                                                                                                         quality assessments                                                            

  1.2 Develop local SOPs and\                                                    1.2.1 Develop procedures governing data\                Trials unit heads, QA staff, operational managers,\                            Example SOPs and proformas
  related quality documents\                                                     sharing planning and procedures within a trial.         senior data management and IT staff                                            
  supporting aspects of IPD and\                                                                                                                                                                                        
  data object sharing                                                                                                                                                                                                   

  1.2.2 Develop procedures and libraries to\                                     Trials unit operational managers, statisticians,\       Links to standards and associated\                                             
  promote the use of data standards in database\                                 senior data management and IT staff                     resources. Example local procedures\                                           
  and metadata design.                                                                                                                   Libraries of re-usable components                                              

  1.3 Clarify and integrate own\                                                 1.3.1 Clarify / agree with relevant university,\        Trials unit heads, QA staff, operational managers,\                            
  institution's requirements for\                                                hospital (etc.) any policies and requirements\          equivalent staff in parent organisation(s)                                     
  data sharing                                                                   (e.g. use of local data repositories) concerning\                                                                                      
                                                                                 data sharing.                                                                                                                          

  1.3.2 Integrate any institutional requirements into\                           Trials unit heads, QA staff, operational managers                                                                                      
  local SOPs and procedures.                                                                                                                                                                                            

  2\. Plan for data sharing, *in the context of a specific trial*                                                                                                                                                       

  2.1 Decide the strategy for data\                                              2.1.1 Explore options for data sharing\                 Sponsors, with trial management team and\                                      Checklist of issues that need to be\
  sharing for this trial.                                                        (considering datasets, timeframe, likely de-\           network of investigators                                                       considered, with supporting material,\
                                                                                 identification required, planned journal (s), likely\                                                                                  option descriptions
                                                                                 repository, costs, etc.)                                                                                                               

  2.1.2 Check funder/sponsor requirements for\                                   Trial management team, funder and / or sponsor\         Classification of legal responsibilities of\                                   
  data sharing                                                                   staff                                                   different parties involved                                                     

  2.1.3 Decide the strategy and specific actions\                                Sponsors, with trial management team                    Checklist of issues that need to be\                                           
  required for data sharingin this trial                                                                                                 considered, with supporting material,\                                         
                                                                                                                                         option descriptions                                                            

  2.2 Document the strategy for\                                                 2.2.1 Incorporate data sharing summary in\              Trial management team                                                          Example protocol sections
  data sharing for this trial in trial\                                          section of the protocol                                                                                                                
  documents                                                                                                                                                                                                             

  2.2.2 Incorporate data sharing details within the\                             Trial management team, data management /\               Example DMP sections with supporting\                                          
  data management plan                                                           sharing specialists                                     material                                                                       

  2.2.3 Incorporate data sharing summary within\                                 Trial management team                                   Example registry data sections                                                 
  trial registration data                                                                                                                                                                                               

  2.3 Incorporate information\                                                   2.3.1 Summarise and explain data sharing plan\          Trial management team, patient groups and\                                     Guidance on legislation framework\
  on data sharing plan into\                                                     in patient information sheets.                          representatives                                                                -- demonstration material, templates,\
  participant documents of\                                                                                                                                                                                             examples
  clinical trials                                                                                                                                                                                                       

  2.3.2 Include request for broad consent for data\                              Trial management team, patient groups and\              Demonstration material, templates,\                                            
  sharing in informed consent documents.                                         representatives                                         examples                                                                       

  2.4 Check and align data\                                                      2.4.1 Ensure any plans to publish collaborators'\       Trial management team                                                          Examples of possible issues (e.g. with\
  sharing plans of collaborators\                                                data (e.g. lab data) are compatible with plans for\                                                                                    expectations of publishing lab data,\
  who are also generating data.                                                  clinical IPD sharing                                                                                                                   increased re-identification risk)

  2.4.2 Ensure all collaborators have contributed to\                            Trial management team                                   Examples of possible processes, policies,\                                     
  and have agreed to data sharing plans.                                                                                                 to agree and document data sharing\                                            
                                                                                                                                         across collaborators.                                                          

  2.5 Ensure that data and\                                                                                                              Trial management team                                                          Links to standards and associated\
  metadata standards have been\                                                                                                                                                                                         resources. Libraries of re-usable\
  used as far as possible in\                                                                                                                                                                                           components
  database design                                                                                                                                                                                                       

  3\. Preparation of data for sharing, after data collected                                                                                                                                                             

  3.1 Confirm strategy for\                                                      3.1.1 Decide if (further) pseudonymisation or\          Trial data management and IT staff                                             Guidance on interpretation of legal\
  data preparation for sharing,\                                                 anonymisation required.                                                                                                                requirements in different jurisdictions.
  including timelines                                                                                                                                                                                                   

  3.1.2 Assess risk of re-identification with existing\                          Trial data management and IT staff, specialist de-\     De-identification/anonymisation service for\                                   
  datasets. Confirm types and level of de-\                                      identification agencies                                 datasets                                                                       
  identification required.                                                                                                                                                                                              

  3.2 Carry out strategy for data\                                               3.2.1 De-identify, and pseudo-anonymise or\             Trial data management and IT staff, specialist de-\                            De-identification/anonymisation service for\
  preparation                                                                    anonymise dataset for data sharing                      identification agencies                                                        datasets

  3.2.2 Check that analyses still function for de-\                              Statisticians and data managers                                                                                                        
  identified data and document any\                                                                                                                                                                                     
  discrepancies                                                                                                                                                                                                         

  3.2.3 Generate / transform, and check,\                                        Trial data management and IT staff                                                                                                     
  descriptive metadata for the datasets prepared\                                                                                                                                                                       
  for sharing                                                                                                                                                                                                           

  3.2.4 Select file formats for long term storage of\                            Trial data management and It staff                      File formats recognized as standard                                            
  data and metadata and transform if necessary                                                                                                                                                                          

  3.3 Document data preparation\                                                 3.3.1 Assess and document risk of re-\                  Trial data management and IT staff, specialist de-\                            De-identification/anonymisation service for\
  process                                                                        identification with revised datasets                    identification agencies                                                        datasets. template Data Protection Impact\
                                                                                                                                                                                                                        Assessments.

  3.3.2 Incorporate record of data preparation and\                              Trial data management and IT staff                      Metadata scheme for describing de-\                                            
  risk assessments within metadata                                                                                                       identification and data preparation\                                           
                                                                                                                                         processes                                                                      

  4\. Transferring data objects to external repository                                                                                                                                                                  

  4.1 Select repository (or confirm\                                             4.1.1 Explore repository features, management,\         Sponsors with trial management team                                            Data repository identification service\
  earlier repository selection)                                                  access options, costs, certification                                                                                                   including assessment against quality\
                                                                                                                                                                                                                        criteria, standards, certification process\
                                                                                                                                                                                                                        for repositories

  4.2 Transfer the datasets\                                                     4.2.1 Agree on access regime, data\                     Sponsors with trial management team                                            Checklists to support data transfer\
  under a formal data transfer\                                                  sharing decision processes, assignment of\                                                                                             agreement
  agreement                                                                      responsibilities including data controller role                                                                                        

  4.2.2 Agree on responsibilities for generating\                                Sponsors with trial management team                     Checklists to support data transfer\                                           
  discoverability and provenance metadata                                                                                                agreement                                                                      

  4.2.3 Draw up and agree data transfer\                                         Sponsors with trial management team                     Tools for generating data transfer\                                            
  agreement, including provision if repository\                                                                                          agreement                                                                      
  disappears                                                                                                                                                                                                            

  4.2.4 Apply discoverability and provenance\                                    Trial data management and IT staff and/or\              Metadata schemas for data object\                                              
  metadata to datasets and transfer data                                         repository staff                                        discoverability; tools for their application                                   

  5\. Repository data and access management                                                                                                                                                                             

  5.1 Maintain highly granular\                                                  5.1.1 Maintain access control that allows\              Repository managers                                                            Authentication and authorisation tools,\
  access control to IPD                                                          individual files to be designated as either\                                                                                           logging services
                                                                                 \                                                                                                                                      
                                                                                 a) publicly available, without user identification,\                                                                                   
                                                                                 to download or simply view.\                                                                                                           
                                                                                 \                                                                                                                                      
                                                                                 b) available only to *self-identified* named\                                                                                          
                                                                                 individuals, to download or simply view (may be\                                                                                       
                                                                                 managed on a group basis).\                                                                                                            
                                                                                 \                                                                                                                                      
                                                                                 c) available only to named individuals,\                                                                                               
                                                                                 *as identified by data controllers*, to download or\                                                                                   
                                                                                 simply view (may be managed on a group basis).                                                                                         

  5.1.2 Maintain 2-factor authentication, as\                                    Repository managers                                     Authentication and authorisation tools with\                                   
  required, with either (b) or (c) from 5.1.1.                                                                                           2 factor authentication (see ^[4](#FN4){ref-type="other"}^ at the bottom\      
                                                                                                                                         of [Table 1](#T1){ref-type="table"})                                           

  5.2 Maintain mechanisms to set\                                                5.2.1 Provide web based forms that allow users\         Repository managers                                                            Authentication and authorisation tools,\
  up and apply authentication\                                                   to provide details about themselves, with some\                                                                                        validation mechanisms
  and authorization measures                                                     degree of validation (e.g. email confirmation,\                                                                                        
                                                                                 cross reference to other AAI architectures).                                                                                           

  5.2.2 Provide appropriate log-in pages, with\                                  Repository managers                                     Authentication and authorisation tools                                         
  password management                                                                                                                                                                                                   

  5.3 Where there is a demand,\                                                  5.3.1 Allow datasets (including, possibly some\         Repository managers, analysis environment\                                     The analysis environment itself, including\
  provide a protected analysis\                                                  imported from other repositories) to be identified\     providers                                                                      data import and logging tools
  environment                                                                    and requested for a designated analysis\                                                                                               
                                                                                 environment                                                                                                                            

  5.3.2 Provide viewing, analysis and recording\                                 Repository managers, analysis environment\              Analysis tools and services, logging tools                                     
  tools, while preventing download of the data.                                  providers                                                                                                                              

  5.3.3 Provide workflow recording tools and\                                    Repository managers, analysis environment\              Workflow recording tools, logging tools                                        
  documentation of the whole process, including\                                 providers                                                                                                                              
  the closure / teardown of the specific analysis\                                                                                                                                                                      
  environment.                                                                                                                                                                                                          

  5.4 Supply discovery data\                                                     5.4.1 Liaise with metadata repositories to agree\       Repository managers                                                            Schema for discovery metadata
  for IPD and data objects on\                                                   a metadata schema that conforms with, or can\                                                                                          
  a regular basis to metadata\                                                   be mapped to, a general schema for discovery\                                                                                          
  repositories                                                                   metadata                                                                                                                               

  5.4.2 Allow regular (e.g. nightly) harvesting of\                              Repository managers                                     API for making metadata available from\                                        
  metadata, through an API.                                                                                                              each repository                                                                

  5.5 Facilitate data access\                                                    5.5.1 Establish a Data Access Committee, for\           Repository managers, Data Access Committee\                                    Guidelines for terms of reference /\
  according to prior Data Transfer\                                              data that requires this type of controlled access,\     members                                                                        functioning of Data Access Committees;\
  Agreement                                                                      which can process and filter requests, and\                                                                                            mechanisms for recording and publication\
                                                                                 recommend or take decision on data release.                                                                                            of Access Committee decisions

  5.5.2 For data that requires them, create and\                                 Repository managers                                     Template and example data request\                                             
  post data request forms for users to complete.                                                                                         forms                                                                          

  5.5.3 For data that requires them, create\                                     Repository managers                                     Template and example data use\                                                 
  templates that allow potential users to see the\                                                                                       agreements (may be starting points for\                                        
  information they will need to provide, and the\                                                                                        negotiated, specific, agreements)                                              
  conditions to which they will need to conform.                                                                                                                                                                        

  5.6 Provide usage and status\                                                  5.6.1 Provide regular (e.g. quarterly) reports\         Repository managers                                                            Report services maintained by repository\
  reports to data depositors                                                     on access and / or requests made, by whom,\                                                                                            managers
                                                                                 actions taken and reasons given, back to the\                                                                                          
                                                                                 data generators and / or controllers                                                                                                   

  5.6.2 Provide regular (e.g. annual) reports on\                                Repository managers                                     Report services maintained by repository\                                      
  management of data security and integrity,\                                                                                            managers                                                                       
  changes in infrastructure, funding and\                                                                                                                                                                               
  organisation, etc., to all users                                                                                                                                                                                      

  6 Managing access to individual participant data and associated data objects                                                                                                                                          

  6.1 Manage direct responses\                                                   6.1.1 Decide upon the possibility, in legal terms,\     Sponsors and trial management team                                             Guidance on interpretation of legal\
  to the sponsors or coordinating\                                               of making the data available to others at all.                                                                                         requirements in different jurisdictions, for\
  investigators, in case no legal\                                                                                                                                                                                      different levels of consent
  sponsor is available (data not\                                                                                                                                                                                       
  yet in a repository)                                                                                                                                                                                                  

  6.1.2 Assess the reasonableness of the request\                                Sponsors and trial management team                                                                                                     
  and the ability of the requesters to draw sensible\                                                                                                                                                                   
  conclusions                                                                                                                                                                                                           

  6.1.3 Assess the costs of de-identifying the data,\                            Sponsors and trial management team                      Data on costs in data preparation\                                             
  preparing metadata, etc.                                                                                                               exercises                                                                      

  6.1.4 Make a final decision as to whether to\                                  Sponsors and trial management team                                                                                                     
  share the data with the requester.                                                                                                                                                                                    

  6.1.5 Draw up a data use agreement and transfer\                               Sponsors and trial management team                      Example data use agreements                                                    
  the data under its terms                                                                                                                                                                                              

  6.2 Manage access to data in\                                                  6.2.1 Repository makes appropriate request\             Repository managers                                                            Available forms on line (see 5.5)
  a repository (if access requests\                                              forms available on-line                                                                                                                
  individually reviewed)                                                                                                                                                                                                

  6.2.2 Request forms completed and submitted\                                   Secondary users                                                                                                                        
  (on or off-line)                                                                                                                                                                                                      

  6.2.3 (If stipulated in data transfer agreement)\                              Sponsors or advisory panel                                                                                                             
  Request passed to advisory panel for\                                                                                                                                                                                 
  assessment and recommendation, otherwise to\                                                                                                                                                                          
  data controllers                                                                                                                                                                                                      

  6.2.4 Decision to allow request made, by Data\                                 Sponsors or Data Access Committee, or\                  Guidelines for terms of reference /\                                           
  Access Committee if stipulated in data transfer\                               repository managers                                     functioning of Data Access Committees                                          
  agreement, otherwise by data controllers                                                                                                                                                                              

  6.2.5 If positive decision, data use agreement\                                Sponsors or advisory panel, repository\                 Example data use agreements                                                    
  drawn up and agreed                                                            managers, secondary users                                                                                                              

  6.2.6 Data access arranged after liaison with\                                 Sponsors or advisory panel, repository managers         Pipeline for quick processing of access\                                       
  repository managers                                                                                                                    change requests                                                                

  6.2.7 Access request and decision documented                                   Sponsors or advisory panel, repository managers         Recording systems for request and\                                             
                                                                                                                                         decision                                                                       

  7\. Discovering the data                                                                                                                                                                                              

  7.1 Agree a common discovery\                                                                                                          Repository managers, metadata repository\                                      The metadata scheme itself
  metadata standard                                                                                                                      managers                                                                       

  7.2 Agree and implement an\                                                    7.2.1 Develop, and cost a mechanism for\                Repository managers, metadata repository\                                      Existing ID supply mechanisms, especially\
  ID generation scheme for data\                                                 generating persistent IDs for data objects.             managers                                                                       DOIs
  objects                                                                                                                                                                                                               

  7.2.2 Implement the process for generating\                                    Trial teams, repository and metadata repository\        The ID generation mechanism itself                                             
  persistent IDs (e.g. DOIs) for data objects.                                   managers                                                                                                                               

  7.3 Agree and implement an ID\                                                 7.3.1 Use existing (multiple) study identifiers as\     Repository managers, metadata repository\                                      Existing IDs, from registries, sponsors,\
  generation scheme for clinical\                                                far as possible                                         managers, (etc!)                                                               funders etc.
  studies                                                                                                                                                                                                               

  7.3.2 Attempt to develop an ID generation and /\                               Repository, metadata repository and registry\           Existing ID supply mechanisms, especially\                                     
  or assignment process for *all* clinical studies                               managers, WHO, etc!                                     registry IDs                                                                   

  7.4 Collect metadata together\                                                 7.4.1 Collect existing metadata samples and\            Metadata repository managers                                                   The metadata scheme from 7.1, the ID\
  into a public metadata\                                                        sources into a prototype metadata repository                                                                                           schemes from 7.2, 7.3;
  repository, under a single portal                                                                                                                                                                                     

  7.4.2 Maintain the metadata by arranging regular\                              Metadata repository managers                            The metadata scheme from 7.1, the\                                             
  harvesting (e.g. nightly, using API and metadata\                                                                                      ID schemes from 7.2, 7.3; Metadata\                                            
  scheme)                                                                                                                                harvesting tools                                                               

  7.4.3 Develop a single portal for searching\                                   Metadata repository managers                                                                                                           
  through the metadata                                                                                                                                                                                                  

  7.4.4 Federate additional metadata sources\                                    Metadata repository managers                                                                                                           
  under the same portal                                                                                                                                                                                                 

  7.5 Search for the data objects\                                                                                                       Secondary users                                                                Search tools using study identifiers, name,\
  concerned with a trial or clinical\                                                                                                                                                                                   and / or object identifiers. Receive data on\
  study                                                                                                                                                                                                                 location and access details.

  8\. Publishing results of re-use                                                                                                                                                                                      

  8.1 Carry out secondary use\                                                   8.1.1 Publish re-analysis, preferably open (e.g.\       Secondary users                                                                
  and publish results                                                            peer reviewed journal)                                                                                                                 

  8.1.2 If successful, ensure proper citation of data\                           Secondary users                                         Agreed schemes for citation and credit\                                        
  and credit to data generators.                                                                                                         for data                                                                       

  8.1.3 Whether or not published in a journal,\                                  Secondary users, repository managers                                                                                                   
  publish summary results and relevant datasets\                                                                                                                                                                        
  -- usually in source repository.                                                                                                                                                                                      

  8.1.4 Apply metadata to new data objects,\                                     Secondary users                                         Metadata scheme for discoverability                                            
  ensure harvesting into metadata system.                                                                                                                                                                               

  9\. Monitoring data sharing                                                                                                                                                                                           

  9.1 Monitor data sharing activity                                              9.1.1 Gather and disseminate data on data\              Repository managers                                                            Web site on which to display collected\
                                                                                 requests (where explicit requests are required).                                                                                       data

  9.1.2 Gather and disseminate data on reasons\                                  Repository managers                                     Web site on which to display collected\                                        
  for request refusal (where explicit requests are\                                                                                      data                                                                           
  required).                                                                                                                                                                                                            

  9.1.3 Gather and disseminate data on data\                                     Repository managers                                     Web site on which to display collected\                                        
  accesses, downloads etc.                                                                                                               data                                                                           

  9.2 Monitor output and\                                                        9.2.1 Attempt to monitor output of data sharing\        Publishers, funders                                                            Web site on which to display collected\
  consequences of data sharing                                                   activity and associated research (papers,\                                                                                             data
                                                                                 datasets etc.).                                                                                                                        

  9.2.2 Attempt to monitor level and outcome of\                                 Publishers, funders, individual researchers             Published papers                                                               
  disputes that may occur after data sharing and\                                                                                                                                                                       
  re-analysis                                                                                                                                                                                                           

  9.2.3 Attempt to monitor changing attitudes\                                   Individual researchers                                  Published papers                                                               
  towards data sharing in clinical research                                                                                                                                                                             
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^1^ **Data objects**: any discrete packages of data in an electronic form -- whether that data is textual, numerical, a structured dataset, an image, film clip, (etc.) in form. They are each a file, as that term is used within computer systems, and are named, at least within their source file system. In the context of clinical research and data sharing, data objects can include electronic forms of protocols, journal papers, patient consent forms, analysis plans, and any other documents associated with the study, as well as datasets representing different portions and types of the data generated, and the metadata describing that data.

^2^ **SOP**: Standard Operating Procedure -- A controlled document, explicitly versioned, reviewed and approved, that outlines the roles and responsibilities involved in a particular task and / or workflow, and the subtasks, deliverables and associated documentation required. SOPs may be supplemented by more detailed 'work instructions', that may relate to using one or more specific systems.

^3^ **Authentication**: The process of ensuring that a person or system that is trying to access a system is who they say (it says) they are. With a person, authentication is by provision of one or more of something only they should know (e.g. a password), or should have (e.g. a card or fob), or can show (e.g. fingerprint, iris pattern). With a system it is more often by provision of a secret token (in effect a machine password), often derived from public key cryptography.

^4^ **Two factor authentication**: The simultaneous use, by a person, of two of the three authentication methods described above.

^5^ **Authorisation**: The process of giving an authenticated entity the rights to access particular subsets of data and/or to carry out particular functions within a system. It is usually carried out by assigning user entities to roles and to groups that together define the access allowed.

In [Table 2](#T2){ref-type="table"}, the possible services and / or tools associated with this activity are grouped according to major types of support, with a reference to the subprocesses where they may provide support. As the table illustrates, these tools and services fall into 6 (overlapping) categories:

1\. Providing general background material

2\. Locator services (for resources for data sharing, and / or to support data standards)

3\. Example documents and templates

4\. Services (e.g. to de-identify data, assign IDs, provide metadata, evaluate repositories)

5\. Frameworks and guidance (e.g. metadata schemas, citation systems, checklists)

6\. Tools (IT based, e.g. APIs to harvest repository contents, tools to assign metadata)

###### Classification and description of possible tools/services to support processes in sharing IPD from clinical trials.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Type of service/tool                                                                          Description/comments                                                                                                                                                             Reference to\
                                                                                                                                                                                                                                                                                 process ( [Table 1](#T1){ref-type="table"})
  --------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------
  **1. Providing general background material**                                                                                                                                                                                                                                   

  Providing general\                                                                            Collection of relevant resources about data sharing *in general* -- e.g.\                                                                                                        1.1.1
  background material                                                                              •   Links to papers and relevant policy documents from an annotated bibliography,\                                                                                            
                                                                                                   •   Summary documents (e.g. built around recent consensus paper) and web pages\                                                                                               
                                                                                                   •   Glossary of terms\                                                                                                                                                        
                                                                                                   •   Links to general educational and training resources provided elsewhere\                                                                                                   
                                                                                                   •   Courses, webinars, books using materials above\                                                                                                                           
                                                                                                   •   Meetings, conference sessions looking at aspects of data sharing and related topics\                                                                                      
                                                                                                   •   Advice to citizens, ethics committees                                                                                                                                     

  **2. Locator services**                                                                                                                                                                                                                                                        

  List of general resources to\                                                                 Annotated links to web sites that provide (for example) ...\                                                                                                                     1.1.2
  support data sharing                                                                             •   Data on repositories for storage of datasets and other data objects (see ^[1](#ref-1){ref-type="other"}^ at the bottom of [Table 1](#T1){ref-type="table"}), and their\   
                                                                                                facilities, terms of service etc.\                                                                                                                                               
                                                                                                   •   Data on services to aid in de-identification\                                                                                                                             
                                                                                                   •   Information on the applicable legal framework(s)\                                                                                                                         
                                                                                                   •   Links to model agreements templates that can be adapted to meet the particular circumstances of data sharing\                                                             
                                                                                                   projects.                                                                                                                                                                     

  List of resources to support\                                                                 Annotated links to\                                                                                                                                                              1.2.2, 2.5
  greater use of data\                                                                             •   Repositories of standard data items, e.g. within CDISC's CDASH, CFAST.\                                                                                                   
  standards                                                                                        •   Repositories of standard data instruments, e.g. CDISC QRS (questionnaires, ratings and scales)\                                                                           
                                                                                                   •   Metadata schemes\                                                                                                                                                         
                                                                                                   •   Core outcome sets (e.g. COMET)                                                                                                                                            

  **3. Example documents**                                                                                                                                                                                                                                                       

  Example documents\                                                                               •   Example SOPs, (see ^[2](#ref-2){ref-type="other"}^ at the bottom of [Table 1](#T1){ref-type="table"}),\                                                                   1.2.1, 2.1,\
  supporting data sharing\                                                                         •   Supporting relevant checklists, forms\                                                                                                                                    2.4.1,\
  processes                                                                                     Covering all aspects of data sharing, e.g.\                                                                                                                                      2.4.2
                                                                                                   •   During study preparation, or as part of long term data management, in the context of pre-defined collaborations,\                                                         
                                                                                                or when handling requests for access.\                                                                                                                                           
                                                                                                   •   Use of data standards in study design\                                                                                                                                    
                                                                                                   •   Use of metadata for data description, data object discovery\                                                                                                              
                                                                                                   •   Examples of data sharing policies (universities, research institute)\                                                                                                     
                                                                                                   •   Examples of data sharing requests from funders or journals                                                                                                                

  Example data sharing\                                                                         Examples of possible\                                                                                                                                                            2.2.1, 2.2.2,\
  documents (for trial set up)                                                                     •   Sections of a protocol\                                                                                                                                                   2.2.3, 2.3.1,\
                                                                                                   •   Sections of a Data Management Plan\                                                                                                                                       2.3.2,\
                                                                                                   •   Trial Registry sections\                                                                                                                                                  2.4.1
                                                                                                   •   Participant information sheets\                                                                                                                                           
                                                                                                   •   Consent forms\                                                                                                                                                            
                                                                                                   •   Proformas, for agreements with collaborators\                                                                                                                             
                                                                                                   •   Proformas, for using lab and genetic data\                                                                                                                                
                                                                                                All dealing with aspects of *planning* for data sharing and publication plans, available as a central resource. These\                                                           
                                                                                                could then be used / adapted in the context of individual trials.                                                                                                                

  Example data sharing\                                                                         Examples / templates of possible\                                                                                                                                                4.2.1, 4.2.3
  documents (for data\                                                                             •   Data transfer agreements\                                                                                                                                                 
  transfer)                                                                                        •   Relevant sections of a Data Management Plan\                                                                                                                              
                                                                                                   •   Checklists for the data transfer process                                                                                                                                  

  Example data sharing\                                                                         Examples of\                                                                                                                                                                     5.5.3, 6.1.5
  documents (for data re-use)                                                                      •   Data request forms\                                                                                                                                                       
                                                                                                   •   Data use agreements\                                                                                                                                                      
                                                                                                   •   Checklists to support the development of a data use agreement                                                                                                             

  **4. Services**                                                                                                                                                                                                                                                                

  De-identification /\                                                                          There are four possible services here --\                                                                                                                                        3.1.2, 3.2.1,\
  anonymisation service for\                                                                       •   Resources that allow trials units to develop their own de-identification/anonymisation processes (if compliant with\                                                      3.3.1, 3.3.2
  datasets                                                                                         legal considerations).\                                                                                                                                                       
                                                                                                   •   Consultancy input to advise on de-identification in the context of a particular trial\                                                                                    
                                                                                                   •   Services that carry out and document a de-identification process on behalf of the sponsor / trials unit\                                                                  
                                                                                                   •   Service for assessment of risk of re-identification                                                                                                                       

  Descriptive metadata\                                                                         To be useful (easily searchable, comparable etc.) the descriptive metadata of the data needs to be in a standard\                                                                3.2.3, 3.3.2
  services for datasets                                                                         format, or one of a few recognised standard formats (e.g. CDISC ODM). Mechanisms and / or services to convert\                                                                   
                                                                                                proprietary metadata descriptions into such a format could therefore be useful when required.                                                                                    

  Assessment / certification\                                                                   Provision of a set of standards, that can be used to assess the suitability of any repository as a location for data object\                                                     4.1.1, 4.2.1
  service for data repositories                                                                 storage, would act as a useful guide to the potential users of those repositories.\                                                                                              
                                                                                                The further application of such standards within a certification scheme                                                                                                          

  An ID assignment\                                                                             An ID (e.g. doi) generation service is required for all stored data objects.                                                                                                     7.2.1, 7.2.2
  mechanism for data objects                                                                                                                                                                                                                                                     

  A common pipeline for\                                                                        With the possibility of many different data repositories emerging storing clinical datasets, there is potential advantage\                                                       6.2.6
  processing access requests                                                                    from making the application, review, decision making process for each very similar (e.g. using common application\                                                               
                                                                                                proformas) or even managing those processes together, e.g. with a common expert advisory board.\                                                                                 
                                                                                                This could ultimately create a common 'request pipeline'.                                                                                                                        

  Recording and reporting\                                                                      Reports that could be provided by repositories include\                                                                                                                          5.6.1, 6.2.7, 9.1.1,\
  systems for data access\                                                                         •   Level and type of data object deposition\                                                                                                                                 9.1.2, 9.1.3
  requests and episodes                                                                            •   The types of data access arrangements in place\                                                                                                                           
                                                                                                   •   Numbers and types of access requests\                                                                                                                                     
                                                                                                   •   The decisions reached and reasons for rejections\                                                                                                                         
                                                                                                Data objects generated as a result of data re-use.                                                                                                                               

  Provision of a prototype\                                                                     A metadata repository, (or a\                                                                                                                                                    7.4.1, 7.4.2, 7.4.3,\
  metadata repository                                                                           portal linked to multiple such repositories) with discovery metadata for clinical trial data\                                                                                    7.4.4, 7.5
                                                                                                objects, is seen as a fundamental requirement if data sharing is going to work efficiently.                                                                                      

  Service for provision of a\                                                                   Based on tools to provide an analysis environment for in-situ work (see below).                                                                                                  5.3.1, 5.3.2, 5.3.3
  secure analysis environment                                                                                                                                                                                                                                                    

  **5. Frameworks and guidance**                                                                                                                                                                                                                                                 

  The development of a\                                                                         Agreement is needed on a common discovery metadata standard that can link data objects to studies and that can\                                                                  4.2.4, 5.4.1, 5.4.2,\
  discovery metadata schema                                                                     describe the access mechanisms associated with each.\                                                                                                                            7.1
                                                                                                Proposals have been made, based on an existing scheme (DataCite) but need further development.                                                                                   

  The development of an\                                                                        There needs to be a universally recognised scheme that will allow fair credit for the re-use of data, in terms of\                                                               8.1.2
  agreed scheme for citation\                                                                   academic citation and recognition.                                                                                                                                               
  of re-use                                                                                                                                                                                                                                                                      

  Legal and regulatory\                                                                         As the legal and regulatory environment continues to evolve, there will be an ongoing need to clarify the legal\                                                                 2.1.2, 2.3.1, 3.1.1,\
  framework                                                                                     responsibilities of the major parties involved in data sharing by update relevant resources (e.g. templates, legal issues\                                                       6.1.1
                                                                                                database, procedures). and keep researchers and data managers informed of any relevant changes in laws, policies,\                                                               
                                                                                                and regulations\                                                                                                                                                                 
                                                                                                Such a service could usefully be a central resource. It could not be a legal service as such (i.e. answering specific\                                                           
                                                                                                questions) but it could provide a general framework for guidance.                                                                                                                

  Checklist to decide the\                                                                      Checklist of issues to be considered of data sharing, with supporting material, option descriptions                                                                              2.1.1, 2.1.2, 2.1.3
  strategy for data sharing                                                                                                                                                                                                                                                      

  Checklist to support\                                                                         Checklist to support development of data transfer agreement/data use agreement                                                                                                   4.2.1, 4.2.2
  specification of agreements                                                                                                                                                                                                                                                    

  Manual to establish boards\                                                                   Manual for advisory panel/board                                                                                                                                                  5.5.1, 6.2.4
  overseeing data sharing                                                                                                                                                                                                                                                        

  **6. Tools**                                                                                                                                                                                                                                                                   

  Tools to support the\                                                                         A tool is required to allow the easy application of the metadata schema used to characterize data objects, ideally by\                                                           4.2.4, 8.1.4
  application of discovery\                                                                     the object generators and if not by repository managers.\                                                                                                                        
  metadata scheme                                                                               This would likely take the shape of a set of web based forms, linked to a central repository.                                                                                    

  Tools for de-identification /\                                                                See de-identification / anonymisation service for datasets above,                                                                                                                3.1.2, 3.2.1,\
  anonymisation service for\                                                                                                                                                                                                                                                     3.3.1, 3.3.2
  datasets                                                                                                                                                                                                                                                                       

  Authentication and\                                                                           Highly granular access is needed (at the level of individual users / individual data objects) to support the variety of\                                                         5.1.1, 5.1.2,\
  authorisation systems for\                                                                    controlled access mechanisms likely to be required in repositories                                                                                                               5.2.1, 5.2.2
  repository access (see ^[3](#ref-3){ref-type="other"}^ and ^[5](#ref-5){ref-type="other"}^\                                                                                                                                                                                    
  at the bottom of [Table 1](#T1){ref-type="table"})                                                                                                                                                                                                                             

  Provide an analysis\                                                                          Interest has been expressed in a mechanism that allows data to be examined, re-analysed, aggregated etc. without\                                                                5.3.1, 5.3.2, 5.3.3
  environment for *in-situ* work                                                                being downloaded first, but instead kept within a secured, tailored, 'analysis environment', which also contains the\                                                            
                                                                                                analysis tools required. In fact several different types of tools would be required, for:\                                                                                       
                                                                                                   •   Environment creation (e.g. as a container)\                                                                                                                               
                                                                                                   •   Data import and logging\                                                                                                                                                  
                                                                                                   •   Authentication and authorisation\                                                                                                                                         
                                                                                                   •   Analysis\                                                                                                                                                                 
                                                                                                   •   Workflow recording\                                                                                                                                                       
                                                                                                   •   Environment destruction                                                                                                                                                   

  APIs to access repository\                                                                    When discovery data is not (or has not been) directly transferred to a central repository using the tools described\                                                             5.4.1, 5.4.2
  catalogue data (for\                                                                          above, it will be necessary to try and 'harvest' metadata from data repositories on a regular basis.\                                                                            
  metadata aggregation)                                                                         Using APIs that give access to the repository catalogues is a key part of that, and is much cheaper than trying to use\                                                          
                                                                                                'data mining' techniques, e.g. natural language parsing on data object titles, to link data objects to studies.                                                                  

  Tools for generation of data\                                                                 Software tools supporting the development of data transfer/data use agreements.                                                                                                  4.2.3, 6.1.5, 6.2.5
  transfer agreements/data\                                                                                                                                                                                                                                                      
  use agreements                                                                                                                                                                                                                                                                 
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Discussion
==========

Within the framework of the EU H2020 funded project CORBEL major issues associated with sharing of IPD were investigated and a consensus document on providing access to IPD from clinical trials was developed, using a broad interdisciplinary approach ^[@ref-6]^. The taskforce reached consensus on 10 principles and 50 recommendations, representing the fundamental requirements of any framework used for the sharing of clinical trials data. To support the adoption of the recommendations, adequate tools and services are needed to promote and support data sharing and re-use amongst researchers, adequately inform trial participants and protect their rights, and provide effective and efficient systems for preparing, storing, and accessing data. As a first step on the way to inventory existing tools/services, their quality and applicability for data sharing, a systematic analysis of processes and actors involved in data sharing was performed. The work done resulted in a systematic, structured and comprehensive list of processes and subprocesses that need to be supported to make data sharing a reality in the future. It is basic work against which existing tools and and services can be mapped, and allowing gaps in service provision to be identified. It is outside the scope of this paper to address issues about data sharing (e.g. recognition of the effort of the original researcher, self-identification of patients). This has been addressed in the CORBEL consensus exercise ^[@ref-6]^.

In the context of this work, we explored the possibility of generating a generic frameork for the sharing of IPD from clinical trials. As an example we considered the Framework for Open Science and Research by ATT (see [Open Science and Research framework](https://openscience.fi/framework-for-open-science)). This framework provides a general description of a desired architecture in a domain of open science, defining the key structural elements of the overall solution and describing their interactions, using an Enterprise Architecture (EA) approach. It can thereby give an overview of how various research processes, actors and services -- including data, data structures, and IT-systems -- could form an interoperable system in the 'target' open state. The work done in developing a framework for open science and research could be of major relevance for a similar model in the area of participant data sharing. At this stage, however, of identifying the processes and subprocesses involved, it was felt to be too early to develop a generic framework. It may be that this approach will be taken up again once there is confidence that the components for such a framework have been identified.

Nevertheless, we thought it useful to use a standardised terminology and notation for describing basic processes in data sharing. This will simplify the extension to a more generic and comprehensive framework at a later stage. As one approach, business modelling has been applied successfully in the health and health research area. It has been used, for example, to perform a requirements analysis of the barriers to conducting research linking of primary care, genetic and cancer data ^[@ref-7]^, to model the complexity of health and associated data flow in asthma ^[@ref-8]^ and to provide a generic architecture for a type 2 diabetes mellitus care system ^[@ref-9]^. We decided not to apply the full spectrum of business process modelling (BPMN), but to use only basic elements to give a notational and terminological basis for further work. More work is needed to explore the suitability and benefit of BPMN for a generic framework for data sharing.

Different models for clinical trials and clinical trials workflow already exist, such as the domain analysis model BRIDG ^[@ref-10]^, the study design model CDISC SDM ^[@ref-11]^ and the primary care information model PCROM ^[@ref-12]^. Any framework or model for data sharing needs to map or reference these clinical trial models, though none currently include the secondary use of data after the trial has completed. Although clinical trial processes and data sharing processes are distinct, they are clearly linked, and any comprehensive model needs to incorporate those linkages.

Many of the services and tools identified in this paper are non-technical but nevertheless may be of major importance, especially for data generators and data requestors. This includes templates and examples, checklists and guidance. For some of the processes specified in this paper IT-tools and services already exist and can be applied (e.g. de-identification tools and services, see [Electronic Health Information Laboratory page on de-identification software](http://www.ehealthinformation.ca/faq/de-identification-software-tools/)), others are under development but need further work or an extension in scale (e.g. metadata repository for identifying clinical trial objects, ^[@ref-13]^). This work could also be used as input to an update of the EMA data sharing policy, currently discussing the possibility of sharing individual participant data (IPD) from clinical trials (see [EMA page of clinical data publication policy](http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/general/general_content_000556.jsp&mid=WC0b01ac05809f363f)). The next step is to perform a scan on the availability and suitability of services and tools for data sharing based on this work, with the involvement of stakeholders. We will summarize this information in a separate report.

Data availability
=================

The data referenced by this article are under copyright with the following copyright statement: Copyright: © 2018 Ohmann C et al.

Data associated with the article are available under the terms of the Creative Commons Zero \"No rights reserved\" data waiver (CC0 1.0 Public domain dedication). <http://creativecommons.org/publicdomain/zero/1.0/>

All data underlying the results are available as part of the article and no additional source data are required.
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In this paper, Ohmann et. al. perform a detailed analysis of steps required to share patient microdata from clinical trials with the research community. They provide a process diagram describing the workflow of preparing, transferring and maintaining the data and metadata to an external repository. The main part of the work consists of a comprehensive list of all sub-processes, the involved actors and services or tools. They also elaborate on scope and depth of the services or tools and give examples.

The valuable contribution of this work lies in the sequential structuring of data sharing tasks. Especially study groups who want (or have to) actively provide data have a checklist at hand, which gives them the opportunity to assess each sub-task in its complexity and to put together suitable persons or teams for implementation. This prevents important stakeholders from being overlooked or partial steps from being insufficiently taken into account, particularly with regard to regulatory issues.

The article focuses on aspects of data sharing in clinical trials, addressing a relevant problem of academic research, namely the long-term availability of research results in an environment that has only a limited lifespan due to project funding. It shows the complexity of the topic and every research group should already think about it during the project planning phase. Additionally, it is also relevant for other types of research projects, such as clinical registries, epidemiological cohorts or studies in health care research, with minor modifications.

I particularly liked the fact that aspects of providing analysis environments were also addressed, e.g. with special Docker containers that bring the evaluation algorithms to the data instead of releasing data.

The weak part of the paper is that even with a detailed listing of the sub-processes and the relevant tools, most researchers will find it difficult to design a concrete implementation strategy or to check whether the implementation meets the state of the art. Notes such as \"Provide sample documents\", \"Assess risk of re-identification\" or \"Select suitable metadata schemas for object discovery\" are simply too vague to be a real help. At this point, a knowledge base must be built up that provides researchers with concrete guidelines, implementation guidelines and example scenarios for successful projects.

Points to address: The workflow in Figure 1 assumes that the data set is only imported once into an external repository. However, there are many scenarios in which data sets will have to be updated or extended, e.g. in long-running investigations where interim evaluations are already being carried out. Snapshots of shared data must be saved for verification purposes.Some years ago, there has been an EMA draft policy on publication and access to clinical-trial data [\[1\]](http://www.ema.europa.eu/ema/index.jsp?curl=pages/includes/document/document_detail.jsp?webContentId=WC500144730&mid=WC0b01ac058009a3dc). I'm not sure about the current status but it would be interesting to include the effort in this paper.Page 6, section 2.3.2 "Include request for broad consent for data sharing in informed consent documents." The term broad consent might require a more detailed definition, because in Germany consent is always contextual and without specific and the ethics committees are looking into this.Metadata (sections 2.5, 5.4, 7.1) should not be limited to semantics and discovery. Another important topic for metadata is provenance metadata (measurement conditions, data quality, algorithms for calculated data)

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

Ohmann

Christian

ECRIN, Germany

**Competing interests:**No competing interests were disclosed.
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***Our answer in bold and italics***. 

In this paper, Ohmann et. al. perform a detailed analysis of steps required to share patient microdata from clinical trials with the research community. They provide a process diagram describing the workflow of preparing, transferring and maintaining the data and metadata to an external repository. The main part of the work consists of a comprehensive list of all sub-processes, the involved actors and services or tools. They also elaborate on scope and depth of the services or tools and give examples.

The valuable contribution of this work lies in the sequential structuring of data sharing tasks. Especially study groups who want (or have to) actively provide data have a checklist at hand, which gives them the opportunity to assess each sub-task in its complexity and to put together suitable persons or teams for implementation. This prevents important stakeholders from being overlooked or partial steps from being insufficiently taken into account, particularly with regard to regulatory issues.

The article focuses on aspects of data sharing in clinical trials, addressing a relevant problem of academic research, namely the long-term availability of research results in an environment that has only a limited lifespan due to project funding. It shows the complexity of the topic and every research group should already think about it during the project planning phase. Additionally, it is also relevant for other types of research projects, such as clinical registries, epidemiological cohorts or studies in health care research, with minor modifications.

I particularly liked the fact that aspects of providing analysis environments were also addressed, e.g. with special Docker containers that bring the evaluation algorithms to the data instead of releasing data.

The weak part of the paper is that even with a detailed listing of the sub-processes and the relevant tools, most researchers will find it difficult to design a concrete implementation strategy or to check whether the implementation meets the state of the art. Notes such as \"Provide sample documents\", \"Assess risk of re-identification\" or \"Select suitable metadata schemas for object discovery\" are simply too vague to be a real help. At this point, a knowledge base must be built up that provides researchers with concrete guidelines, implementation guidelines and example scenarios for successful projects.

***The purpose of the study was better explained at the end of the introduction. It was the objective to identify all processes/sub-processes involved in data sharing and to provide a classification of tools/services needed to support the processes. It is ground structuring work and it was not intended to provide specific help for data sharing (e.g. guidelines, examples).*** ***In a later stage of the CORBEL project concrete and speciifc tools/services to support data sharing will be made availalbe.***

Points to address: The workflow in Figure 1 assumes that the data set is only imported once into an external repository. However, there are many scenarios in which data sets will have to be updated or extended, e.g. in long-running investigations where interim evaluations are already being carried out. Snapshots of shared data must be saved for verification purposes.***This is a relevant point and was included in the figure under 3) : Preparation of data sharing (after data collected or data update. ***Some years ago, there has been an EMA draft policy on publication and access to clinical-trial data [\[1\]](http://www.ema.europa.eu/ema/index.jsp?curl=pages/includes/document/document_detail.jsp?webContentId=WC500144730&mid=WC0b01ac058009a3dc). I'm not sure about the current status but it would be interesting to include the effort in this paper.***The EMA policy 70 is effective since January 2015 and applies to new drugs approved by the EMA after that date, thus only on a subset of trials testing pharmacological interventions.*** ***Moreover, the policy is only dealing with clinical study reports, i.e. aggregate data.  Currently, the EMA is discussing the possibility of sharing individual participant data (IPD) from clinical trials. One EMA expert was included in our consensus exercise and one author of the current paper (CO) was invited to attend an EMA-workshop on anonymisation, 30.11.-1.12.2017). This publication could be used as input to an update of the EMA data sharing policy. This comment is added to the discussion. ***Page 6, section 2.3.2 "Include request for broad consent for data sharing in informed consent documents." The term broad consent might require a more detailed definition, because in Germany consent is always contextual and without specific and the ethics committees are looking into this.***The concept of broad consent has been discussed in detail in the BMJ Open paper published by the group in 2017.and was not tackled in this manuscript. ***Metadata (sections 2.5, 5.4, 7.1) should not be limited to semantics and discovery. Another important topic for metadata is provenance metadata (measurement conditions, data quality, algorithms for calculated data)***Yes, provenance data are very important and an essential part of the metadata.  We have added provenance metadata in 4.2.2 and 4.2.4.***
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Version 1

This process-orientated manuscript covers a lot of ground in some detail. I have some specific comments:

**Major**  Section: GeneralComment: The process of reaching these recommendations is unclear to me. Perhaps these are opinions? I don't think there is primary evidence to underpin them. Should there be?Section: GeneralComment: This is comprehensive, but also sets out a substantial burden on organisations. I wonder for what proportion of trials this work is proportionate effort.Section: GeneralComment: This does not address my previous concerns about recognition of effort of the original researchers or issues about self-identification by patients, but perhaps that is outside of the scope of the paper. It would helpful to remind the reader that these are key, unresolved issues and point to places where they might be considered further. ** **

**Moderate ** Section: Table 1Text ref: \"1.2 Clarify own institution's requirements for data sharing\"Comment: This is pretty vague. I don't know how to use this row.Section: Table 1Text ref: \"2.1.2 Check funder requirements for data sharing\"Comment: Which takes priority and when? 2.1.2 vs 1.2.Section: Table 1Text ref: \"2. Plan for data sharing, in the context of a specific trial\"Comment: When should this be developed? 2.2.2 suggests before the protocol is finalised; but I suspect 2.2.2 would generally be done before 2.2.1. What is the ordering of the rows?Section: Table 1Text ref: \"3.1 Decide upon strategy for data preparation for sharing\"Comment: 3.1.1 and 3.1.2 seem to be in the wrong order.Section: Table 1Text ref: Section 3 or 4Comment: Somewhere, perhaps, one should advertise the timelines for making data available. It's unlikely to be during the trial; how long after primary analyses? Useful to manage expectations?Section: Table 1Text ref: \"5.1 Maintain highly granular access control to IPD, that can be changed rapidly\"Comment: Changed on what basis?Section: Table 1Text ref: \"5.5 Provide an expert advisory panel\"Comment: Is this a Data Access Committee or something different? Is there independent membership?Section: Table 1Text ref: \"5.7 Provide data use agreement templates\"Comment: Possibly wishful thinking. Agreements are never as straightforward as one might hope. Is this a suggestion for global templates, institution templates or trial templates?Section: Table 1Text ref: \"6.1.2 Assess the reasonableness of the request and the ability of the requesters to draw sensible conclusions\"Comment: Where is the independence in this process? Is there a duty from the sponsor and TMG to work fairly? Who judges what is reasonable?Section: Table 1Text ref :: \"6.2.1 Repository makes appropriate request forms available on-line\"Comment: Why? This will just encourage false positive submissions. Better for applicants to talk to the trial team before getting a form, so the applicant really understands whether the data set is suitable and timely. (Very often, it really won't be.)Section Table 1Text refL \"7.2 Agree an ID generation scheme for data objects\"Comment: Also, what if the same dataset is given to two separate people: does this get the same ID?Section: Table 1Text ref: \"8. Publishing results of re-use\"Comment: Who checks that the secondary use of the data is done well?Section: Table 1Text ref: \"8. Publishing results of re-use\"Comment: What to do if there is discrepancy in findings between original and subsequent findings? Could undermine trust. Probably needs rows about "dispute" resolution.Section: Table 2Text ref: \"2. Locator services. Locator service for data sharing resources\"Comment: Will this be a familiar term to readers? I'm not sure what it means.  

**Trivial/Minor ** Section: Table 1Comment: Would be quickly for each actor to find the role if this column was broken into separate columns, one per actor type, with the ticks for whether it is relevant.Section: Table 1Text ref: \"7.2 Agree an ID generation scheme for data objects\"Comment: "Data objects" needs a clear definition before the table. Perhaps a Glossary with the Abbreviations?

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

Ohmann

Christian

ECRIN, Germany

**Competing interests:**No competing interests were disclosed.
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***Response to  reviewer in bold and italics***

This process-orientated manuscript covers a lot of ground in some detail. I have some specific comments:

  

**Major**  Section: GeneralComment: The process of reaching these recommendations is unclear to me. Perhaps these are opinions? I don't think there is primary evidence to underpin them. Should there be?***Principles and recommendations on data sharing were developed in the BMJ Open paper. In this study a framework based upon these principles and recommendations was proposed, characterising processes/suprocesses as well as tools/services needed for data sharing.  T*** ***he following methodological approach was followed. The basic concepts and definitions were adapted from the business process model and notation (BPMN) and applied to our analysis.*** ***Recommendations and principles from the data sharing consensus document were analysed in detail and individual processes/subprocesses identified and linked to actors and possible services/tools by a small group of experts (CO, SC, RB, WK, SB).  The decision-making process was based on a facilitator (CO) providing initial and updated versions of the document and iterative rounds of written feedback from the team members.  The process was continued until final agreement was achieved. The process took place between October 2017 and January 2018, four different versions were provided and approved in sequential order (24 November 2017, 7 and 11 December 2017, 15 January 2018).  Due to the good relationship between the team members and long-term involvement in common projects, a comprehensive and detailed point of reference, the consensus document, and clear objectives with milestones and time lines, agreement could be achieved by the team without applying a normative model of decision-making.  As suggested by another reviewer, this paper can be classified as qualitative research, although we applied a semi-formal collaborative small group decision-making approach and not formal methodology such as interviews or focus groups.*** ***We revised the methodological section of the manuscript and adapted it as much as possible to the COREQ guidelines for qualitative research.***Section: GeneralComment: This is comprehensive, but also sets out a substantial burden on organisations. I wonder for what proportion of trials this work is proportionate effort.***This is difficult to estimate. The empirical assessment of the benefit of data sharing in comparison to the effort and resources needed is an area, where much more research is needed. *** ***This issue has been explored in more detail in the BMJ Open publication but was not tackled in this paper*** ***. ***Section: General Comment: This does not address my previous concerns about recognition of effort of the original researchers or issues about self-identification by patients, but perhaps that is outside of the scope of the paper. It would helpful to remind the reader that these are key, unresolved issues and point to places where they might be considered further.***These aspects have been discussed in detail in the BMJ open publication and are outside the scope of this paper.  As suggested, readers are reminded that the points raised  by the reviewer are key unsolved issues and initiatives dealing with these issues are referred to. *Moderate ** Section: Table 1 Text ref: \"1.2 Clarify own institution's requirements for data sharing\"Comment: This is pretty vague. I don't know how to use this row.***This was split into two subprocesses and a comment was added in the table. The order of 1.2 and 1.3 was reversed. ***Section: Table 1 Text ref: \"2.1.2 Check funder requirements for data sharing\"Comment: Which takes priority and when? 2.1.2 vs 1.2.***Certainly a reasonable question but so far no priorities have been defined  and the timely order of processes has only be lightly tackled in the figure. The work is part of ongoing research in the CORBEL project.  *** ***A comment about \"clarification of legal responsibilities\" has been added in 2.1.2. ***Section: Table 1 Text ref: \"2. Plan for data sharing, in the context of a specific trial\"Comment: When should this be developed? 2.2.2 suggests before the protocol is finalised; but I suspect 2.2.2 would generally be done before 2.2.1. What is the ordering of the rows?***Correct, the order of 2.2.1 and 2.2.2 has been reversed. ***Section: Table 1Text ref: \"3.1 Decide upon strategy for data preparation for sharing\"Comment: 3.1.1 and 3.1.2 seem to be in the wrong order.***We have not changed that because from our viewpoint this seems to be the right order. ***Section: Table 1 Text ref: Section 3 or 4Comment: Somewhere, perhaps, one should advertise the timelines for making data available. It's unlikely to be during the trial; how long after primary analyses? Useful to manage expectations?***This is an important issue, which has also been discussed in the BMJ Open paper. We have included a reference to timelines in 3.1. ***Section: Table 1 Text ref: \"5.1 Maintain highly granular access control to IPD, that can be changed rapidly\"Comment: Changed on what basis?***We removed the reference to \"rapid change\" as it seems tob e confusing. ***Section: Table 1 Text ref: \"5.5 Provide an expert advisory panel\"Comment: Is this a Data Access Committee or something different? Is there independent membership? ***The reference was changed to a Data Access Committee.*** ***We also re-organised the processes in section 5 to make them (I hope) easier to read and understand, though the content is almost exactly the same. 5.3 and 5.4 were split up into sub-processes, 5.5 -- 5.7 made subprocesses of a new 5.5, and 5.6 (was 5.8) expanded to include 2 subprocesses of reporting / feedback***Section: Table 1Text ref: \"5.7 Provide data use agreement templates\"Comment: Possibly wishful thinking. Agreements are never as straightforward as one might hope. Is this a suggestion for global templates, institution templates or trial templates?***We agree that in practice there will be no agreed templates.*** ***Therefore we added a phrase that the templates may be starting points for negotiated, specific agreements.***Section: Table 1 Text ref: \"6.1.2 Assess the reasonableness of the request and the ability of the requesters to draw sensible conclusions\"Comment: Where is the independence in this process? Is there a duty from the sponsor and TMG to work fairly? Who judges what is reasonable?***Yes, a critical issue. This is the reason why we prefer data sharing via trusted repositories with defined and transparent governance. In 6.1 processes are specified for the use case of access via direct contact with the sponsor/PI. Here an independency of processes is usually not given.***Section: Table 1 Text ref :: \"6.2.1 Repository makes appropriate request forms available on-line\"Comment: Why? This will just encourage false positive submissions. Better for applicants to talk to the trial team before getting a form, so the applicant really understands whether the data set is suitable and timely. (Very often, it really won't be.)***We are supporting the view that data sharing and re-use should be possible without the (mandatory) involvement of data generators. False positive submission may be reduced if the data available are fully described***. ***According to the suggestions of another reviewer, a relation between data requester and data generator named « optional collaboration » has been added to the figure. In our consensus exercise (BMJ Open paper) we formulated the following recommendation (no. 33) :  « Collaboration between data providers and secondary data users could be an added value in data sharing.*** ***However, it should not be a pre-requisite for data sharing. ». Therefore we marked the relation with « optional ».***Section Table 1 Text refL \"7.2 Agree an ID generation scheme for data objects\"Comment: Also, what if the same dataset is given to two separate people: does this get the same ID?***Yes, the ID is fixed with the clinical trial objects.*** ***7.2. is now split into two related subprocesses, as is 7.3. 7.1. and 7.5 simplified by removal of subprocess.***Section: Table 1 Text ref: \"8. Publishing results of re-use\"Comment: Who checks that the secondary use of the data is done well?***Yes, this is a critical issue.*** ***There is no standard procedure foreseen for this. The best strategy is to make the re-analysis fully open and transparent.*** ***(see 8.1.1). In that case the scientific community (including the data generators) can check the validity of the re-analysis.  Nevertheless, monitoring compliance (in general) is an open issue but not impossible. FDAA Trial Tracker is a good example of monitoring compliance to regulation in trial registry and Ben Goldacre's group is also chasing  and publishing non-compliance. ***Section: Table 1 Text ref: \"8. Publishing results of re-use\"Comment: What to do if there is discrepancy in findings between original and subsequent findings? Could undermine trust. Probably needs rows about "dispute" resolution.***Yes, also very important and difficult to solve.*** ***Replication is very important in science (*** ***<https://www.nature.com/news/1-500-scientists-lift-the-lid-on-reproducibility-1.19970>*** ***) and given that the replication of complex and expensive experiments such as trials is not very much feasible, replication of the analysis is fundamental.*** ***We cannot think of any formal structure, to 'referee' disputes, that would be applicable here -- any dispute would need to be played out in the literature, and each is likely to have different characteristics. We have restructured section 9 to add a row about the need to monitor disputes, as well as other possible consequences.***Section: Table 2 Text ref: \"2. Locator services. Locator service for data sharing resources\"Comment: Will this be a familiar term to readers? I'm not sure what it means.***We have tried to reword section 2 to make the meaning clearer.*** **Trivial/Minor ** Section: Table 1 Comment: Would be quickly for each actor to find the role if this column was broken into separate columns, one per actor type, with the ticks for whether it is relevant. ***Table 1 ordered according to actor is an interesting proposal but according to our approach (list all processes/sub-processes following the clinical workflow) it would mean to add another table. We would not prefer to do that to keep the paper as  simple as possible.***Section: Table 1 Text ref: \"7.2 Agree an ID generation scheme for data objects\"Comment: "Data objects" needs a clear definition before the table. Perhaps a Glossary with the Abbreviations?***Yes, a glossary with some main terms (defined as used in this paper) was added at the bottom of table 1.***
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Version 1

The manuscript Classification of processes involved in sharing individual participant data from clinical trials by Ohmann C, Canham S, Banzi R, Kuchinke W and Battaglia S ^[@rep-ref-31016-1]^ is more than useful for all stakeholders interested in data sharing. It must be accepted with, in my opinion, a few (and minor) edits. 

In my experience as a researcher interested in the impact of data sharing policies ^[@rep-ref-31016-2]^, I have identified that a major practical barrier to implementation of full data sharing of randomised controlled trials was the great heterogeneity across different trial groups: \"getting prepared and preplanning for data sharing still seems to be a challenge for many trial groups; data sharing proved to be novel for some authors who were unsure how to proceed\". Therefore the description and classification of processes involved in sharing IPD from clinical trials will surely helps all stakeholders to get prepared. It is welcome and this manuscript will be very useful. 

I have a few suggestions that may help to write it better. Please note that I\'m not an expert in qualitative research. Therefore these are only suggestion that I don\'t want to enforce strongly. 

First, as it is presented as a research paper and because it is very qualitative by nature, I would suggest to use, or better adapt the reporting guidelines for qualitative research ^[@rep-ref-31016-3]^ to this specific paper as most points won\'t directly apply since the study presented is not a typical qualitative research. 

More specifically, I would welcome more details on authors in the main text: 

\- Who are they? Were they from different background (e.g. data managers, statisticians, trialists, patients, etc\..., Master degree, MD, PhD, PharmD\... etc.). Please clearly state that they were involved in the initial initiative that was used for this paper ^[@rep-ref-31016-4]^. Please also detail how it could have affected their judgement. 

\- What is their background for conducting such a qualitative synthesis?

\- Was there a protocol registered for this analysis? 

Please specify why the processes were derived from only one initiative ^[@rep-ref-31016-4]^ and not from a systematic assessment of other papers/initiatives. Any limitations of the initial paper should be discussed here.

The process of analysis should be made as transparent as possible. How the different authors were involved in the process? Were there some leaders during the phone meetings? Were verbatim from written correspondence used? Was there a good agreement between expert (for what parts the agreement was less good ?)? The researchers' own position should also clearly be stated. A critical examination of their own role, possible bias, and influence on the research would be welcome. 

I have also identified very practical points that could be addressed in a new version of the manuscript: 

\- In my very practical experience ^[@rep-ref-31016-2]^, figure 1 could be overly simple for being accurate. I think that one important point was missed. Adoption of data sharing in biomedical research not only implies to provide and re-use the data. It implies to adopt a collaborative approach. It means that when one want to re-use the data of another team, one sometimes must directly contact the other team to have information and to have the data in the appropriate format. Sharing data for a re-analysis of safety outcomes involves sharing the cases report forms while re-using data for some IPD meta-analysis may only rely on sharing data at a later analytical stage (e.g. analysable data). This implies that step 3 is very linked with step 6. I think that the figure will be better (if it is not too complex) by adding such kind of relationship. 

\- Table 1, section 1.1.1 / 2.3.1: patients are an important actors/leverages and must be involved in my opinion in these aspects ;

\- Table 1, in general avoid abbreviations such as \"SOP\" in 1.3 ; 

\- Table 1, section 2 and 3.1: Ethic committees have a strong role to play at all these parts. They have, in my opinion to judge wether the de-identification plan is adapted to the specific study ; 

\- Table 1, section 3.2.1: data manager and statisticians must ensure that the code that will be shared works for the de identified data sets. Practical finding from my experience (in one case, de-identification was made after the analysis and labels were different between the two datasets : therefore the shared code didn\'t worked).

\- Table 1, section 4.1.1: this should be explored before in my opinion (at step 3), when one decide of the data sharing plan. 

\- Table 2 very interesting, but I would suggest to add an hyperlink to some concrete examples when possible in section 3.

In general the tables should be checked for majuscule and minuscule: eg. table 2, section 3 \"during\" must be During. 

A last suggestion would be to add more practical information for clinicians and to cite the ICJME recommandations. 

It is again a very great manuscript and I hope that these comment will be able to improve it. 

I\'m not competent to review the English, and please excuse my English.

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

Ohmann

Christian

ECRIN, Germany

**Competing interests:**No competing interests were disclosed.
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***Response to the reviewer in bold and italics ***

The manuscript Classification of processes involved in sharing individual participant data from clinical trials by Ohmann C, Canham S, Banzi R, Kuchinke W and Battaglia S [^1^](https://f1000research.com/articles/7-138/v1#rep-ref-31016-1) is more than useful for all stakeholders interested in data sharing. It must be accepted with, in my opinion, a few (and minor) edits. 

In my experience as a researcher interested in the impact of data sharing policies [^2^](https://f1000research.com/articles/7-138/v1#rep-ref-31016-2), I have identified that a major practical barrier to implementation of full data sharing of randomised controlled trials was the great heterogeneity across different trial groups: \"getting prepared and preplanning for data sharing still seems to be a challenge for many trial groups; data sharing proved to be novel for some authors who were unsure how to proceed\". Therefore the description and classification of processes involved in sharing IPD from clinical trials will surely helps all stakeholders to get prepared. It is welcome and this manuscript will be very useful. 

I have a few suggestions that may help to write it better. Please note that I\'m not an expert in qualitative research. Therefore these are only suggestion that I don\'t want to enforce strongly. 

First, as it is presented as a research paper and because it is very qualitative by nature, I would suggest to use, or better adapt the reporting guidelines for qualitative research [^3^](https://f1000research.com/articles/7-138/v1#rep-ref-31016-3) to this specific paper as most points won\'t directly apply since the study presented is not a typical qualitative research. 

More specifically, I would welcome more details on authors in the main text: 

\- Who are they? Were they from different background (e.g. data managers, statisticians, trialists, patients, etc\..., Master degree, MD, PhD, PharmD\... etc.). Please clearly state that they were involved in the initial initiative that was used for this paper [^4^](https://f1000research.com/articles/7-138/v1#rep-ref-31016-4). Please also detail how it could have affected their judgement. 

\- What is their background for conducting such a qualitative synthesis?

\- Was there a protocol registered for this analysis? 

Please specify why the processes were derived from only one initiative [^4^](https://f1000research.com/articles/7-138/v1#rep-ref-31016-4) and not from a systematic assessment of other papers/initiatives. Any limitations of the initial paper should be discussed here.

The process of analysis should be made as transparent as possible. How the different authors were involved in the process? Were there some leaders during the phone meetings? Were verbatim from written correspondence used? Was there a good agreement between expert (for what parts the agreement was less good ?)? The researchers' own position should also clearly be stated. A critical examination of their own role, possible bias, and influence on the research would be welcome. 

***We agree with the reviewer that this paper can be classified as qualitative research, although we applied a semi-formal collaborative small group decision-making approach and not a formal methodology such as interviews or focus groups.*** ***We revised the manuscript and adapted it as much as possible to the COREQ guidelines.. However, as expected, many COREQ items are clearly not applicable. We hope this revision had improved the paper reporting.*** ** **

I have also identified very practical points that could be addressed in a new version of the manuscript: 

\- In my very practical experience [^2^](https://f1000research.com/articles/7-138/v1#rep-ref-31016-2), figure 1 could be overly simple for being accurate. I think that one important point was missed. Adoption of data sharing in biomedical research not only implies to provide and re-use the data. It implies to adopt a collaborative approach. It means that when one want to re-use the data of another team, one sometimes must directly contact the other team to have information and to have the data in the appropriate format. Sharing data for a re-analysis of safety outcomes involves sharing the cases report forms while re-using data for some IPD meta-analysis may only rely on sharing data at a later analytical stage (e.g. analysable data). This implies that step 3 is very linked with step 6. I think that the figure will be better (if it is not too complex) by adding such kind of relationship. 

***According to the suggestions of the reviewer, a relation between data requester and data generator named « optional collaboration » has been added to the figure. In our consensus exercise (BMJ Open paper)  we formulated the following recommendation (no. 33) :  « Collaboration between data providers and secondary data users could be an added value in data sharing. However, it should not be a pre-requisite for data sharing. ». Therefore we marked the relation with « optional ».*** 

\- Table 1, section 1.1.1 / 2.3.1: patients are an important actors/leverages and must be involved in my opinion in these aspects ;

***Added patient groups to list of actors for 1.1.1, 2.3.1 and 2.3.2***

\- Table 1, in general avoid abbreviations such as \"SOP\" in 1.3 ; 

***A brief definition has been added to the glossary of at the bottom of table 1..***

\- Table 1, section 2 and 3.1: Ethic committees have a strong role to play at all these parts. They have, in my opinion to judge wether the de-identification plan is adapted to the specific study ; 

***We are not sure if the exact role of ethics committees in data sharing has been clarified, though if the proposals are in the protocol and the participant information sheet (etc.) they would be scrutinised by an ethics committee.  Not sure if this needs to be added explicitly as part of the workflow unless ECs are given a formal role.***

\- Table 1, section 3.2.1: data manager and statisticians must ensure that the code that will be shared works for the de identified data sets. Practical finding from my experience (in one case, de-identification was made after the analysis and labels were different between the two datasets : therefore the shared code didn\'t worked).

***An extra subprocess has been added as 3.2.2.***

\- Table 1, section 4.1.1: this should be explored before in my opinion (at step 3), when one decide of the data sharing plan. 

***We are not so sure. This will never be a simple linear process, so the order in the table does not imply a similar ordering of workflow. We have changed 4.1. so that it is either a selection or a confirmation of an earlier repository selection.***

\- Table 2 very interesting, but I would suggest to add an hyperlink to some concrete examples when possible in section 3.

***Table 1 and 2 were improved, taken the comments from the reviewer into consideration.***

In general the tables should be checked for majuscule and minuscule: eg. table 2, section 3 \"during\" must be During.

***Checked.***

A last suggestion would be to add more practical information for clinicians and to cite the ICJME recommandations. 

***The activity  of ICMJE was cited.***

It is again a very great manuscript and I hope that these comment will be able to improve it. 

I\'m not competent to review the English, and please excuse my English.

[^1]: No competing interests were disclosed.
